Kai Harting

Title: Innovations by Kai Harting in Neurotoxin Research

Introduction

Kai Harting is an accomplished inventor based in Frankfurt, Germany. He has made significant contributions to the field of neurotoxin research, particularly through his innovative methods for generating neurotoxin-sensitive neuronal cells. His work has implications for understanding the biological activities of neurotoxin polypeptides.

Latest Patents

Kai Harting holds 2 patents related to cellular test systems for determining the biological activities of neurotoxin polypeptides. His latest patent describes a method for generating neurotoxin-sensitive, neuronal differentiated cells. This method involves cultivating tumor cells capable of differentiating into neuronal cells under specific conditions. The process includes steps for priming these cells and cultivating them in a differentiation medium, ultimately leading to the creation of neurotoxin-sensitive cells. Furthermore, the invention outlines a method for assessing the activity of neurotoxin polypeptides using these specialized cells.

Career Highlights

Kai Harting is currently associated with Merz Pharma GmbH & Co KGaA, where he continues to advance his research in neurotoxin biology. His work is characterized by a commitment to innovation and scientific excellence.

Collaborations

Kai collaborates with Karl-Heinz Eisele, who is also involved in the research and development of neurotoxin-related projects.

Conclusion

Kai Harting's contributions to neurotoxin research through his innovative patents and collaborations highlight the importance of scientific advancements in understanding neurotoxic effects. His work continues to pave the way for future discoveries in this critical area of study.